FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis.
Year: 1999
Type: conference-abstract
Source: PubMed
Authors: I Naasani, H Seimiya, T Yamori, T Tsuruo
Institution: Japanese Foundation For Cancer Research
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2115386682
